Triad Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$488K Buy
1,653
+199
+14% +$59.1K 0.04% 279
2025
Q4
$397K Buy
1,454
+86
+6% +$23.4K 0.04% 315
2025
Q3
$370K Buy
1,368
+78
+6% +$21.2K 0.05% 249
2025
Q2
$356K Buy
1,290
+5
+0.4% +$1.36K 0.07% 193
2025
Q1
$341K Buy
1,285
+32
+3% +$7.89K 0.11% 143
2024
Q4
$291K Buy
+1,253
New +$288K 0.11% 137
2024
Q3
Sell
-935
Closed -$184K 210
2024
Q2
$184K Buy
+935
New +$193K 0.1% 100

Other funds holding CME

Triad Wealth Partners's CME Position: Q1 2026 in Review

Triad Wealth Partners increased its CME Group (CME) stake by 14% in Q1 2026, buying an estimated $59.1K and bringing the position to 1,653 shares worth $488K. The position accounts for 0.04% of the portfolio, ranked #279.

Triad Wealth Partners first reported a position in CME in Q2 2024 and has held it in 7 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Triad Wealth Partners held 1,653 shares of CME Group worth $488K as of Q1 2026.
  • Triad Wealth Partners bought 199 CME Group shares in Q1 2026, an estimated $59.1K.
  • CME Group made up 0.04% of Triad Wealth Partners's portfolio in Q1 2026, its #279 holding.
  • Triad Wealth Partners first reported a position in CME Group in Q2 2024 and has held it in 7 quarters since.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Triad Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.